Experimental mouse lethality of Escherichia coli isolates, in relation to accessory traits, phylogenetic group, and ecological source

Journal of Infectious Diseases

Volumn 194, Issue 8, 2006, Pages 1141-1150

  Johnson, James R ^a,b,d   Clermont, Olivier ^c   Menard, Megan ^a,b   Kuskowski, Michael A ^a   Picard, Bertrand ^c   Denamur, Erick ^c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c INSERM   (France)

^d VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; BACTERIAL PROTEIN; PROTEIN FYUA; PROTEIN MALX; PROTEIN PAP; PROTEIN USP; SIDEROPHORE; UNCLASSIFIED DRUG; YERSINIABACTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CONTROLLED STUDY; ECOLOGY; ENTEROBACTER INFECTION; ESCHERICHIA COLI; FACTORIAL ANALYSIS; FIMBRIA; LETHALITY; MOUSE; MULTIVARIATE ANALYSIS; NONHUMAN; PATHOGENICITY ISLAND; PHYLOGENY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UNIVARIATE ANALYSIS;

ANIMALS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; MICE; MICE, INBRED STRAINS; PHYLOGENY; VIRULENCE;

EID: 33749587567     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/507305     Document Type: Article

References (34)

1. Russo TA, Johnson JR. Medical and economic impact of extraintestinal infections due to Escherichia coli: an overlooked epidemic. Microbes Infect 2003; 5:449-56.
2. Jackson LA, Benson P, Neuzil KM, Grandjean M, Marino JL. Burden of community-onset Escherichia coli bacteremia in seniors. J Infect Dis 2005; 191:1523-9.
3. Picard B, Journet-Mancy C, Picard-Pasquier N, Goullet P. Genetic structures of the B2 and B1 Escherichia coli strains responsible for extraintestinal infections. J Gen Microbiol 1993; 139:3079-88.
4. Johnson JR. Microbial virulence determinants and the pathogenesis of urinary tract infection. Infect Dis Clin North Am 2003; 17:261-78.
5. Johnson JR, Russo TA. Molecular epidemiology of extraintestinal pathogenic (uropathogenic) Escherichia coli. Int J Med Microbiol 2005; 295:383-404.
6. O'Hanley P. Prospects for urinary tract infection vaccines In: Mobley HLT, Warren JW, eds. Urinary tract infections: molecular pathogenesis and clinical management. Washington, DC: ASM Press, 1996:405-25.
7. Johnson JR, Kuskowski M, Denamur E, Elion J, Picard B. Clonal origin, virulence factors, and virulence (letter and reply). Infect Immun 2000; 68:424-5.
8. Escobar-Paramo P, Clermont O, Blanc-Potard A-B, Bui H, Le Bougenec C, Denamur E. A specific genetic background is required for acquisition and expression of virulence factors in Escherichia coli. Mol Biol Evol 2004; 21:1085-94.
9. Donnenberg MS. Microbial determinants of E. coli uropathogenicity [abstract 626]. In: 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (Chicago, IL). Washington, DC: American Society for Microbiology, 2001:509.
10. Sannes MR, Kuskowski MA, Owens K, Gajewski A, Johnson JR. Virulence factor profiles and phylogenetic background of Escherichia coli isolates from veterans with bacteremia versus uninfected control patients. J Infect Dis 2004; 190:2121-8.
11. Johnson JR, Moseley S, Roberts P, Stamm WE. Aerobactin and other virulence factor genes among strains of Escherichia coli causing urosepsis: association with patient characteristics. Infect Immun 1988; 56:405-12.
12. Picard B, Sevali Garcia J, Gouriou S, et al. The link between phylogeny and virulence in Escherichia coli extraintestinal infection. Infect Immun 1999; 67:546-53.
13. McClelland EE, Bernhardt P, Casadevall A. Estimating the relative contributions of virulence factors for pathogenic microbes. Infect Immun 2006; 74:1500-4.
14. Clermont O, Bonacorsi S, Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 2000; 66:4555-8.
15. Hull RA, Gill RE, Hsu P, Minshew BH, Falkow S. Construction and expression of recombinant plasmids encoding type 1 or D-mannose-resistant pili from a urinary tract infection Escherichia coli isolate. Infect Immun 1981; 33:933-8.
16. Blum G, Ott M, Lischewski A, et al. Excision of large DNA regions termed pathogenicity islands from tRNA-specific loci in the chromosome of an Escherichia coli wild-type pathogen. Infect Immun 1994; 62:606-14.
17. Welch R, Burland V, Plunkett G III, et al. Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli. Proc Natl Acad Sci USA 2002; 99:17020-4.
18. Badger JL, Wass CA, Weissman SI, Kim KS. Application of signature-tagged mutagenesis for identification of Escherichia coli K1 genes that contribute to invasion of human brain microvascular endothelial cells. Infect Immun 2000; 68:5056-61.
19. Blattner HR, Plunkett G, Bloch CA, et al. The complete genome sequence of Escherichia coli K-12. Science 1997; 277:1453-74.
20. Johnson JR, Stell AL. Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J Infect Dis 2000; 181:261-72.
21. Johnson JR, Stell AL, Scheutz F, et al. Analysis of F antigen-specific papA alleles of extraintestinal pathogenic Escherichia coli using a novel multiplex PCR-based assay. Infect Immun 2000; 68:1587-99.
22. Johnson JR, Gajewski A, Lesse AJ, Russo TA. Extraintestinal pathogenic Escherichia coli as a cause of invasive non-urinary infections. J Clin Microbiol 2003; 41:5798-802.
23. Pitout JDD, Laupland KB, Church DL, Menard ML, Johnson JR. Virulence factors of Escherichia coli that produce CTX-M-type extended-spectrum b-lactamases. Antimicrob Agents Chemother 2005; 49:4667-70.
24. Sokal RR, Sneath PHA. Construction of a taxonomic system In: Sokal RR, Sneath PHA, eds. Principles of numerical taxonomy. San Francisco: WH Freeman, 1963:169-215.
25. Greenacre M. Correspondence analysis in medical research. Stat Methods Med Res 1992; 1:97-117.
26. Johnson JR. Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev 1991; 4:80-128.
27. Russo TA, McFadden CD, Carlino-MacDonald UB, Beanan JM, Barnard TJ, Johnson JR. IroN functions as a siderophore receptor and is a urovirulence factor in an extraintestinal pathogenic isolate of Escherichia coli. Infect Immun 2002; 70:7156-60.
28. Russo TA, Carlino UB, Johnson JR. Identification of ireA, a novel iron regulated virulence gene in an extraintestinal pathogenic isolate of Escherichia coli. Infect Immun 2001; 69:6209-16.
29. Yamamoto S, Nakano M, Terai A, et al. The presence of the virulence island containing the usp gene in uropathogenic Escherichia coli is associated with urinary tract infection in an experimental mouse model. J Urol 2001; 165:1347-51.
30. Kim KS. Escherichia coli translocation at the blood-brain barrier. Infect Immun 2001; 69:5217-22.
31. Huang S-H, Wan ZS, Chen HM, Jong AY. OmpT contributing to Escherichia coli invasion of human endothelial cells [abstract B-58]. In: American Society for Microbiology 101st General Meeting (Orlando, FL). Washington, DC: American Society for Microbiology, 2001:54.
32. Schubert S, Picard B, Gouriou S, Heesemann J, Denamur E. Yersinia high-pathogenicity island contributes to virulence in Escherichia coli causing extraintestinal infections. Infect Immun 2002; 70:5335-7.
33. Li G, Laturnus C, Evers C, Wieler LH. Identification of genes required for avian Escherichia coli septicemia by signature-tagged mutagenesis. Infect Immun 2005; 73:2818-27.
34. Russo TA, McFadden CD, Carlino-MacDonald UB, Beanan JM, Olson R, Wilding GE. The siderophore receptor IroN of extraintestinal pathogenic Escherichia coli is a potential vaccine candidate. Infect Immun 2003; 71:7164-9.